GelSana

Led by Melissa Krebs, Ph.D., our community member company GelSana is at the forefront of wound care innovation with its highly elastic wound dressing polymers. The company's novel polymer technology helps reduce inflammation at the wound site, providing decreased healing time in diabetic animal trials. Read more about their incredible work in our latest Innovation Spotlight! #WoundCare #Diabetes #FitzCommunityMember

Congratulations to our #FAST alumni, Aluda Pharmaceuticals, Inc., GelSana and Isosterix for showcasing their innovative solutions at today's Startup Stadium during the BIO International Convention! California Life Sciences (CLS) is proud of the remarkable achievements and visionary solutions emerging from our alumni ?? We look forward to continuing our partnership with Biotechnology Innovation Organization, bringing the best of California innovation to the forefront of Startup Stadium. ?? Learn more about each of today's FAST presenting Alumni companies! Aluda: https://bit.ly/3yOH4yp Gelsana: https://bit.ly/4aLIrel Isosterix: https://bit.ly/4e6rFJP #BIO2024 #CaliforniaInnovation #FASTAlumni #StartupStadium

GelSana, an Innosphere Ventures client company, announced today that it has hired Jon Fernandez as Chief Operation Officer. Jon brings a wealth of experience in both product development, including in wound healing, as well as product commercialization. He will drive these efforts at GelSana. “GelSana is fortunate to have Jon join us as we commercialize our first product Cleragel? in the next 9 months,” said Melissa Krebs, Ph.D., CEO and Founder of GelSana. “Jon’s knowledge of topical products, manufacturing, medical devices, and experience in driving growth in early-stage companies is a vital complement to our company as we move into this exciting new phase of our company.” https://lnkd.in/gFECekEi

GelSana announces it has been selected by AFWERX for a Phase II SBIR contract in the amount of $1.25M focused on novel polymers for enhanced wound healing of burns addressing one of the most pressing challenges in the Department of the Air Force (DAF). The Air Force Research Laboratory and AFWERX have partnered to streamline the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) process by accelerating the small business experience through faster proposal to award timelines, changing the pool of potential applicants by expanding opportunities to small business and eliminating bureaucratic overhead by continually implementing process improvement changes in contract execution. The DAF began offering the Open Topic SBIR/STTR program in 2018 which expanded the range of innovations the DAF funded and now on March 14, 2024, GelSana will start its journey to create and provide innovative capabilities that will strengthen the national defense of the United States of America. The Company will be collaborating with Walter Reed Medical Center as part of the contract. “We are honored to have received this contract from AFWERX to develop our unique polymers for combat-related burn injuries,” said Melissa Krebs, CEO of GelSana. “Our polymers repel bacterial adhesion, reduce inflammation in the wound, and prevent the foreign body response. Their unique characteristics also enable sustained release of therapeutics – the combination of which could help reduce infections and recovery timelines, improving outcomes for burns sustained in combat. ”The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government.”